¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"basement membrane dystrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • drum membrane
    °í¸·
  • definitive fetal membrane
    ¿Ï¼ºÅ¾Ƹ·, È®Á¤Å¾Ƹ·
  • dentinoenamel membrane
    »ó¾Æ»ç±âÁú¸·
  • Descemet¡¯s membrane
    µ¥½º¸Þ¸·, µÚ°æ°èÆÇ
  • different membrane protein
    À¯°ü¸·´Ü¹éÁú
  • decidual membrane
    Å»¶ô¸·
  • diphtheritic membrane
    µðÇÁÅ׸®¾Æ¸·
  • excitable membrane
    ÈïºÐ¸·
  • exocoelomic membrane
    ü°­¹Û¸·, ü°­¿Ü¸·
  • extracorporeal membrane oxygenation
    ü¿Ü¸·»ê¼Ò°ø±Þ
  • extracorporeal membrane oxygenator
    ü¿Ü¸·»ê¼Ò°ø±Þ±â
  • effective membrane resistance
    À¯È¿¸·ÀúÇ×
  • egg membrane
    ³­¸·
  • elastic membrane
    ź·Â¸·
  • enamel membrane
    »ç±âÁú¸·
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cloacal membrane
    ¹è¼³°­¸·
  • cricothyroid membrane
    ¹ÝÁö¹æÆÐ¸·
  • critical membrane potential
    ÀӰ踷ÀüÀ§
  • membrane charge
    ¸·ÀüÇÏ
  • membrane conductance
    ¸·Àüµµµµ
  • membrane current
    ¸·Àü·ù
  • decidual membrane
    Å»¶ô¸·
  • definitive fetal membrane
    ¿Ï¼ºÅ¾Ƹ·
  • dentinoenamel membrane
    Çü¼ºÀü¸·, »ó¾Æ»ç±âÁú¸·
  • Descemet¡¯s membrane
    µÚ°æ°èÆÇ, µ¥½º¸Þ¸·
  • different membrane protein
    À¯°ü¸·´Ü¹é
  • diphtheritic membrane
    µðÇÁÅ׸®¾Æ¸·
  • drum membrane
    (¢¡tympanic membrane) °í¸·
  • hyaline membrane disease
    À¯¸®Áú¸·º´
  • membrane dissection
    ¸·ºÐ¸®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • acid, membrane teichoic
    ¸·¼ºÅ¸ÀÌÄÚ»ê
  • acrosomal membrane
    ÷´Üü¸·
  • amnionic membrane
    ¾ç¸·.
  • anal membrane
    Ç×¹®¸·
  • antebrachial interosseous membrane
    ¾Æ·¡ÆÈ»À»çÀ̸·
  • anterior atlanto-occipital membrane
    ¾ÕȯÃßÈĵθ·, ÀüȯÃßÈĵθ·(îñü» õÐý­Ô騝
  • anterior atlanto-occipital membrane
    ¾Õ°í¸®µÚÅë¼ö¸·
  • anterior hyaloid membrane
    ¾ÕÀ¯¸®Ã¼¸·
  • anterior limiting membrane
    ¾Õ°æ°èÆÇ
  • anterior vitreous membrane
    ¾Õ(Àü)À¯¸®Ã¼¸·
  • artificial membrane
    Àΰø¸·(Àΰø¸·).
  • glassy membrane
    À¯¸®¸·.
  • glomerular membrane
    »ç±¸Ã¼¸·(¡­Ø¯).
  • glomerular membrane
    »ç±¸Ã¼¸·.
  • hemochorial membrane
    Ç÷¾×À¶¸ð¸·
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • duchenne muscular dystrophy
    µÚ½Ã¿£´À ±ÙÀ§ÃàÁõ
  • duchenne muscular dystrophy
    µà½Ã¿£Çü ±ÙÀÌ¿µ¾çÁõ(¡­ÐÉì¶ç½å×ñø)
  • dystrophy
    ÀÌ¿µ¾ç
  • dystrophy
    ÀÌ¿µ¾çÁõ(ì¶ç½å×ñø), ¿µ¾ç½ÇÁ¶(ç½å×ã÷ðà), ±â´ÉÀå¾Ö(ѦÒöî¡ ),
  • dystrophy
    ¿µ¾çÀå¾Ö
  • dystrophy (intestinal lipodystrophy)
    ¿µ¾çÀå¾Ö(âÀÚÁö¹æ¿µ¾çÀå¾Ö)
  • dystrophy myotonia
    ±Ù °æÁ÷¼º ÀÌ¿µ¾çÁõ
  • emery-dreifuss muscular dystrophy
    ¿¡¸Ó¸®-µå·¹ÀÌǪ½º ±Ù ÀÌ¿µ¾ç(Áõ)
  • endothelial corneal dystrophy
    °¢¸·³»ÇÇÀÌ¿µ¾ç(Áõ)
  • facioscapulohumeral muscular dystrophy
    ¾È¸é°ß°©»ó¿Ï±ÙÀÌ¿µ¾çÁõ(¡­ì¶ç½å×ñø).
  • fascioscapulohumeral muscular dystrophy
    ¾È¸é°ß°©»ó¿Ï±Ù ÀÌ¿µ¾çÁõ
  • fingerprint dystrophy
    Áö¹®»ó(°¢¸·)ÀÌ¿µ¾ç(Áõ)
  • fleck corneal dystrophy
    ¹ÝÁ¡°¢¸·ÀÌ¿µ¾çÁõ
  • granular corneal dystrophy
    °ú¸³°¢¸·ÀÌ¿µ¾çÁõ.
  • hereditary corneal dystrophy
    À¯Àü¼º °¢¸·ÀÌ ¿µ¾çÁõ.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Seconday tympanic membrane
    µÑ°°í¸·
    [¿¾ ¿ë¾î] Á¦2°í¸·
  • Descemet`s membrane
    µÚ°æ°èÆÇ
    [¿¾ ¿ë¾î] Èİæ°èÆÇ(Descemet¸·)
  • Posterior limiting membrane
    µÚ°æ°èÆÇ
    [¿¾ ¿ë¾î] Èİæ°èÆÇ
  • Posterior atlanto-occipital membrane
    µÚ°í¸®µÚÅë¼ö¸·
    [¿¾ ¿ë¾î] ÈÄȯÃßÈĵθ·
  • Stapedial membrane
    µîÀÚ¸·
    [¿¾ ¿ë¾î] µî°ñ¸·
  • External intercostal membrane
    ¹Ù±ù°¥ºñ»çÀ̸·
    [¿¾ ¿ë¾î] ³úÃø°£¸·
  • External intercostal membrane
    ¹Ù±ù°¥ºñ»çÀ̸·
    [¿¾ ¿ë¾î] ¿Ü´Á°£¸·
  • Outer limiting membrane
    ¹Ù±ù°æ°èÃþ
    [¿¾ ¿ë¾î] ¿Ü°æ°èÃþ
  • External mitochondrial membrane
    ¹Ù±ù»ç¸³Ã¼¸·
    [¿¾ ¿ë¾î] »ç¸³Ã¼¿Ü¸·
  • External glial limiting membrane
    ¹Ù±ù¾Æ±³°æ°è¸·
    [¿¾ ¿ë¾î] ¿Ü±³°æ°è¸·
  • External acrosomal membrane
    ¹Ù±ù÷´Üü¸·
    [¿¾ ¿ë¾î] ÷´Üü¿Ü¸·
  • Outer acrosomal membrane
    ¹Ù±ù÷´Üü¸·
    [¿¾ ¿ë¾î] ¿Ü÷´Üü¸·
  • External elastic membrane
    ¹Ù±ùź·Â¸·
    [¿¾ ¿ë¾î] ¿Üź·Â¸·
  • External nuclear membrane
    ¹Ù±ùÇÙ¸·
    [¿¾ ¿ë¾î] ¿ÜÇÙ¸·
  • Bruch`s membrane
    ¹Ù´Úº¹ÇÕÃþ
    [¿¾ ¿ë¾î] ±âÀúº¹ÇÕü
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • surface membrane proteins
    Ç¥¸é¸·´Ü¹éÁú (øúØüدӱÛÜòõ)
  • unit membrane hypothesis
    ´ÜÀ§¸·¼³(Ó¤êÈØ¯àã)
  • vitelline membrane
    ³­È²¸·(Õ°üÜØ¯)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BMZ basement membrane zone
CBM capillary basement membrane
CSGBM collagenase soluble glomerular basement membrane
EBM electrophysiologic behavior modification; epidermal basement membrane; evidence-based medicine; expr...
GBM glomerular basement membrane
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BMD Becker Muscular Dystrophy
CHED Congenital Hereditary Endothelial Dystrophy
CMD Congenital muscular dystrophy
CMD Congenital myotonic dystrophy
DMD Duchene muscular dystrophy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chorioallantoic membrane inoculation
    À¶¸ð ¿ä¸· Á¢Á¾
  • circulating antibasement membrane antibody
    ¼øÈ¯ Ç×±âÀú¸· Ç×ü
  • cloacal membrane
    ¹è¼³°­ ¸·, ÃÑ ¹è¼³°­ ¸·
  • decidual membrane
    Å»¶ô¸·
  • demarcation membrane
    ºÐ°è ¸·
  • descemets membrane
    µ¥½º¸Þ ¸·
  • excitable membrane
    ÈïºÐ ¸·
  • false membrane
    °¡¸·, À§¸·
  • fertilization membrane
    ¼öÁ¤¸·
    ¾ËÀÌ ¼öÁ¤ÇÑ ÈÄ ¾Ë ÁÖÀ§¿¡ Çü¼ºµÇ´Â ¸·. ¿¹¸¦ µé¸é, ¼º°Ô³ª ºÒ°¡»ç¸®ÀÇ °æ¿ì´Â ¹Ì¼öÁ¤¶õÀº ±× Ç¥¸é¿¡ ¹ÐÂøµÈ ¸Å¿ì ¾ã°í ¿¬ÇÑ ³­¸·À» °¡Áö°í ÀÖ´Ù°¡ ¼öÁ¤À» ÇÒ ¶§´Â ÀÌ ³­¸·ÀÌ Ç¥¸éÀ¸·ÎºÎÅÍ ºÐ¸®ÇÏ¿© ´Ü´ÜÇÏ°í Æ°Æ°ÇÑ ¸·À¸·Î º¯ÇÑ´Ù. À̰ÍÀÌ ¼öÁ¤¸·ÀÌ´Ù. À̰ÍÀº ¾ËÀÌ ¹ß»ý Ãʱâ, Áï ³­ÇÒ¿¡¼­ Æ÷¹è±â ¶§±îÁö ¾ËÀ» º¸È£Çϰųª, °¢ ¼¼Æ÷°¡ »óÈ£ À§Ä¡¸¦ À¯ÁöÇÏ´Â µ¥ µµ¿òÀ» ÁØ´Ù. ¼º°ÔÀÇ °æ¿ì ¹ß»ýÀÌ ÁøÇàµÇ¾î Æ÷¹è±â Á¤µµ¿¡¼­ ºÐºñÇÑ ºÎÈ­ È¿¼Ò°¡ ¼öÁ¤¸·À» ³ì¿© À¯»ýÀÌ ¹Ù´å¼ÓÀ¸·Î Çì¾öÃÄ ³ª°¥ ¼ö ÀÖ°Ô ÇÑ´Ù. ¼öÁ¤¸·°ú ¾Ë Ç¥¸é »çÀÌÀÇ À§¶õ°­¿¡ ÄÝ·ÎÀ̵å»ó ¹°ÁúÀÌ µé¾î ÀÖ´Ù.
  • fibrous membrane
    ¼¶À¯ ¸·
  • human fetal membrane
    »ç¶÷ ÅÂ¾Æ ¸·
  • hyaline membrane disease
    À¯¸®Áú¸·º´
    ¹Ì¼÷¾Æ¿¡¼­ Ãâ»ý Á÷ÈÄ ¹ß»ýÇÏ´Â °¡Àå ÈçÇÑ Áúº´ Áß Çϳª·Î¼­ ½Å»ý¾Æ »ç¸ÁÀÇ Áß¿ä ¿øÀÎÁß ÇϳªÀÌ´Ù.
  • Jacob's membrane
    ÀçÄß ¸·
    ¸Á¸·ÀÇ °£»óÃþ ¹× ÁÖüÃþÀÇ ¼¼Æ÷Ãþ ¸·.
  • line of periodontal membrane
    Ä¡±Ù¸· ¼±
  • lining membrane
    ³»¸·
    ¼¼Æ÷¸·Àº ÁöÁú ÀÌÁß Ãþ ±¸Á¶·Î µÇ¾î ÀÖ°í ±× Áß ¾È ÂÊÀÇ ¸·, ¼¼Æ÷ ÀÚü¸¦ µ¤¾î º¸È£Çϰí ÀÖ´Ù. ¶ÇÇÑ »êÈ­ ÀÛ¿ë¿¡ ÀÇÇØ »ý±ä ±Ý¼ÓÀÇ »êÈ­ ¸·À» ÀÌ·¸°Ô Ç¥ÇöÇϱ⵵ ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
muscular dystrophy A group of diseases characterised by progressive degeneration and/or loss of muscle fibres without nervous system involvement. All or nearly all of them have a hereditary origin but details of the type of genetic defect and of the prognosis for the disease vary from type to type. Duchenne muscular dystrophy (pseudohypertrophic muscular dystrophy) is the most common form. It is due to a sex-linked recessive allele and this is expressed as an absence of the protein dystrophin, the disease in boys shows extensive but insufficient muscle fibre reformation from satellite cells.
(18 Nov 1997)
corneal dystrophy Central corneal opacification, usually bilateral, symmetrical, and often autosomal recessive, involving predominantly epithelial, stromal, or endothelial layers, often in a typical pattern.
(05 Mar 2000)
myotonic dystrophy <neurology> An inherited human neuromuscular disease classed as an autosomal dominant disease in which there is progressive muscle weakening and wasting.
A triplet repeat syndromes (like fragile X syndrome), this most common adult form of muscular dystrophy is caused by expansion of the unstable trinucleotide repeat CTG in the 3' untranslated region on chromosome 19q13 (cAMP-dependent muscle protein kinase gene).
Anticipation has been associated with further expansion of the repeat upon transmission to subsequent generations (the inheritance pattern is autosomal dominant), although contraction has been noted to occur as well. Especially severe neonatal cases have been born to affected mothers preferentially, suggesting a role for genomic imprinting as well.
The classic physical signs include atrophy of facial muscles, cataracts, and delayed muscle relaxation. Detection of the expanded trinucleotide repeat is accomplished by PCR or Southern blot and expansion appears to correlate with decreased transcription of the protein kinase gene.
Inheritance: autosomal dominant.
(29 Dec 1997)
craniocarpotarsal dystrophy Congenital association of skeletal defects (ulnar deviation of hands with camptodactyly, talipes equinovarus, and frontal bone defects) and characteristic facies (protrusion of lips as in whistling, sunken eyes with hypertelorism, and small nose); autosomal dominant inheritance.
Synonym: craniocarpotarsal dysplasia, Freeman-Sheldon syndrome, whistling face syndrome.
(05 Mar 2000)
progressive muscular dystrophy A form of progressive muscular atrophy in which the disease begins in the muscle and not in the spinal centres.
Synonym: Erb atrophy, idiopathic muscular atrophy.
(05 Mar 2000)
progressive tapetochoroidal dystrophy An x chromosome-linked abnormality characterised by atrophy of the choroid and degeneration of the retinal pigment epithelium causing night blindness.
(12 Dec 1998)
scapulohumeral muscular dystrophy One of the less well-defined types of muscular dystrophy, probably heterogenous in nature. Onset usually in childhood or early adulthood and both sexes affected. Characterised by weakness and wasting, usually symmetrical, of the pelvic girdle muscles, the shoulder girdle muscles, or both, but not the facial muscles. Muscle pseudohypertrophy, heart involvement, and mental retardation are absent. Variable inheritance.
Synonym: Leyden-Mobius muscular dystrophy, pelvofemoral muscular dystrophy, scapulohumeral muscular dystrophy.
(05 Mar 2000)
pseudohypertrophic muscular dystrophy The most common childhood muscular dystrophy, with onset usually before age 6. Characterised by symmetrical weakness and wasting of first the pelvic and crural muscles and then the pectoral and proximal upper extremity muscles; pseudohypertrophy of some muscles, especially the calf; heart involvement; sometimes mild mental retardation; progressive course and early death, usually in adolescence. X-linked inheritance (affects males and transmitted by females).
Synonym: childhood muscular dystrophy, Duchenne's disease, pseudohypertrophic muscular dystrophy.
(05 Mar 2000)
hypertrophic dystrophy Increase in the number of cells in a squamous epithelium.
Synonym: hypertrophic dystrophy.
(05 Mar 2000)
neuroaxonal dystrophy A rare disorder that begins in the second year of life and is relentlessly progressive; clinically characterised initially by walking difficulties, weakness, and areflexia, later followed by corticospinal and pseudobulbar findings, blindness, loss of pain appreciation, and mental deterioration; pathologically, eosinophilic spheroids of swollen axoplasm are found in various central nuclei; autosomal recessive inheritance.
(05 Mar 2000)
sympathetic reflex dystrophy A syndrome of pain and tenderness, usually to a hand or foot, associated with vasomotor instability, skin changes and rapid development of bony demineralisation (osteoporosis). Frequently will follow a localised trauma, stroke or peripheral nerve injury.
(27 Sep 1997)
syndrome, reflex sympathetic dystrophy A condition that features a group of typical symptoms, including pain (often burning type), tenderness, and swelling of an extremity associated with varying degrees of sweating, warmth and/or coolness, flushing, discoloration, and shiny skin.
(12 Dec 1998)
Duchenne dystrophy The most common childhood muscular dystrophy, with onset usually before age 6. Characterised by symmetrical weakness and wasting of first the pelvic and crural muscles and then the pectoral and proximal upper extremity muscles; pseudohypertrophy of some muscles, especially the calf; heart involvement; sometimes mild mental retardation; progressive course and early death, usually in adolescence. X-linked inheritance (affects males and transmitted by females).
Synonym: childhood muscular dystrophy, Duchenne's disease, pseudohypertrophic muscular dystrophy.
(05 Mar 2000)
Duchenne muscular dystrophy A specific form of muscular dystrophy that is inherited as a sex-linked recessive trait and thus confined to young males and to females with Turner's syndrome. One third of all cases are estimated to be new mutational events.
See: dystrophin.
It is characterised by degeneration and necrosis of skeletal muscle fibres, that are replaced by fat and fibrous tissue.
Symptoms include muscle weakness and in some forms, the appearance of muscle enlargement (pseudo-hypertrophy). Advanced cases can include weakness of the respiratory muscles (compromising breathing) and cardiomyopathy.
Inheritance: sex-linked recessive.
Incidence: 1 in 4000 male births.
(11 Nov 1997)
dystrophy <pathology> Any disorder arising from defective or faulty nutrition, especially the muscular dystrophies.
Origin: L. Dystrophia, Gr. Trephein = to nourish
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á